Tri-Institutional Therapeutics Discovery Institute expands focus to include antibody drug discovery research

The Tri-I TDI, a partnership established in 2013 to expedite early-stage drug discovery of innovative new small molecule therapies, announced today that it will expand its scope to support the development of antibody drug discovery. More »
Source: The Rockefeller University Newswire - Category: Biomedical Science Authors: Tags: Campus News antibodies antibody therapy Tri-I TDI Source Type: news